Biopharmaceutical process development – Trends/ Challenges/Opportunities
05th July 2019 | 10:30AM GMT/ 3:00PM IST | Kumar Gaurav, Assistant General Manager - Vaccines and Biologics (R&D) at Panacea Biotec |BOOK FREE SEAT
- Current trends and regulation affecting Biopharmaceutical Industry
- Journey from Lab scale to Commercial –Overcoming Scalability design hurdles
- QbD-Bringing Improvements in Biologics development and Manufacturing Space
Presented by Kumar Gaurav, Assistant General Manager – Vaccines and Biologics (R&D) at Panacea Biotec
Kumar Gaurav, Assistant General Manager & Project Lead – Vaccines and Biologics, Panacea Biotec Ltd., is an expert Drug development and Regulatory affairs professional with 15+ years of rich experience in Technical leadership and Strategic planning in development, scale up, technology transfer and regulatory affairs of Vaccines and Biologics
His role is all-encompassing through various stages of product development from conceptualization, development strategy to scale-up, manufacturing operations, Quality compliance, regulatory submissions extending further to commercialization and incremental innovation of marketed products including risk management at each stage.
He is a seasoned professional who has successfully delivered several key projects for the company which are now a major part of the company’s vaccine portfolio and several others which are under various stages of Pre-clinical and Clinical trials gearing up for market launch.